Vaccine Rx Vaccine Rx - Worldwide Vaccine News Updated Daily. http://www.vaccinerx.com 2010-03-10T16:30:30+01:00 FeedCreator 1.7.2 Nuvigil Introduces Co-Pay Assistance 2009-06-03T10:41:55+01:00 2009-06-03T10:41:55+01:00 2009-06-03T10:41:55+01:00 http://www.vaccinerx.com/news/latest/nuvigil-introduces-co-pay-assistance-20090603-591-56.html Cephalon is offering a prescription savings program for Nuvigil, a prescription medicine used to improve wakefulness in adults who experience excessive sleepiness (ES) associated with treated obstructive sleep apnea (OSA), shift work sleep disorder, also known as shift work... CDC Hosts 43rd National Immunization Conference 2009-03-26T03:00:24+01:00 2009-03-26T03:00:24+01:00 2009-03-26T03:00:24+01:00 http://www.vaccinerx.com/news/latest/cdc-hosts-43rd-national-immunization-conference-20090326-590-56.html CDC Media Advisory: CDC Hosts 43rd National Immunization Conference body { font-size: 12px; font-family: arial, verdana, sans-serif; font-weight: normal; font-style: normal; } .physicalAddress { color: gray; font-size: 10px; font-family: arial, verdana, sans-serif; font-weight: 100; }Thousands of health officials from around the country will gather to examine the... Polio Vaccine Chosen for Russia 2008-12-01T03:00:23+01:00 2008-12-01T03:00:23+01:00 2008-12-01T03:00:23+01:00 http://www.vaccinerx.com/news/latest/polio-vaccine-chosen-for-russia-20081201-588-56.html Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that Russia has chosen inactivated polio vaccine (IPV) from Sanofi Pasteur for primary immunization of all infants. The IPV doses are provided by M.P. Chumakov Institute... Nation Teen HPV Vaccination Coverage Increasing, But Below 2010 Goals 2008-12-04T03:00:23+01:00 2008-12-04T03:00:23+01:00 2008-12-04T03:00:23+01:00 http://www.vaccinerx.com/news/cervical-cancer/nation-teen-hpv-vaccination-coverage-increasing-but-below-2010-goals-20081204-586-56.html The nation′s immunization coverage rates for preteens and teens are increasing for routinely recommended vaccines, but most still do not have all of the recommended immunizations, according to 2007 estimates released today by the Centers... Vaccine News: Tablet-Based Vaccine for Allergies 2008-11-27T03:00:23+01:00 2008-11-27T03:00:23+01:00 2008-11-27T03:00:23+01:00 http://www.vaccinerx.com/news/latest/vaccine-news-tablet-based-vaccine-for-allergies-20081127-587-56.html Breakthrough: Results from the fourth year in a long-term clinical study prove the disease modifying effect of GRAZAX®. For the first time ever, it is documented that the positive clinical effect of the tablet vaccine persists after completion... Important Meds and Food for Kids -- Flu Vaccination increasingly important 2008-11-18T03:00:23+01:00 2008-11-18T03:00:23+01:00 2008-11-18T03:00:23+01:00 http://www.vaccinerx.com/news/influenza/important-meds-and-food-for-kids----flu-vaccination-increasingly-important-20081118-585-56.html Flu vaccination rates lag for at-risk adolescents Influenza vaccination rates for adolescents who suffer from asthma and other illnesses are still far too low, according to a recent study. The research, published in the November... What to Expect: HPV Vaccine Gardasil for Men 2008-11-24T03:00:23+01:00 2008-11-24T03:00:23+01:00 2008-11-24T03:00:23+01:00 http://www.vaccinerx.com/news/latest/what-to-expect-hpv-vaccine-gardasil-for-men-20081124-584-56.html The four-type (6,11,16,18) human papillomavirus (HPV) vaccine Gardasil (http://www.medilexicon.com/drugs/gardasil.php)® is also effective in men according to the primary analysis from a pivotal phase III clinical study. In previously uninfected men aged 16 to 26 years*, Gardasil®... Is There a Link between Vaccines and Autism? 2008-11-13T03:00:23+01:00 2008-11-13T03:00:23+01:00 2008-11-13T03:00:23+01:00 http://www.vaccinerx.com/news/latest/is-there-a-link-between-vaccines-and-autism-20081113-583-56.html Imagine a parent who wants to intentionally expose their 13 month old daughter to an infectious disease. That’s what Katie Shutters plans for her daughter, Averie. Shutters hopes to find a child with chicken pox, “so we can... Boots Joins Pampers and UNICEF in 2008 Tetanus Vaccine Initiative 2008-11-17T03:00:23+01:00 2008-11-17T03:00:23+01:00 2008-11-17T03:00:23+01:00 http://www.vaccinerx.com/news/latest/boots-joins-pampers-and-unicef-in-2008-tetanus-vaccine-initiative-20081117-582-56.html Boots has announced that it is joining the Pampers and UNICEF tetanus vaccine initiative for one month during the forthcoming campaign. Each year maternal and newborn tetanus kills approximately 30,000 mothers and 140,000 babies around the world. This... Crestor demonstrates dramatic CV risk reduction in a large statin outcomes study 2008-11-10T11:41:54+01:00 2008-11-10T11:41:54+01:00 2008-11-10T11:41:54+01:00 http://www.vaccinerx.com/news/latest/crestor-demonstrates-dramatic-cv-risk-reduction-in-a-large-statin-outcomes-study-20081110-581-56.html New data from the JUPITER study demonstrated that CRESTOR® (rosuvastatin calcium) (http://www1.astrazeneca-us.com/cgi-bin/az_pi.cgi?product=crestor country=us popup=no) 20 mg significantly reduced major cardiovascular (CV) events (defined in this study as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization... Pitt Scientists Receive $3.6 Million To Test Vaccine Against Deadliest Strain Of Avian Flu 2008-11-04T03:00:23+01:00 2008-11-04T03:00:23+01:00 2008-11-04T03:00:23+01:00 http://www.vaccinerx.com/news/bird-flu/pitt-scientists-receive-3.6-million-to-test-vaccine-against-deadliest-strain-of-avian-flu-20081104-579-56.html Scientists at the University of Pittsburgh Center for Vaccine Research have been awarded $3.6 million from the National Institutes of Health to conduct animal studies of vaccines designed to protect against the most common and deadliest strain of... Emergent BioSolutions Submits Proposal of a Recombinant Protective Antigen Anthrax Vaccine 2008-11-11T03:00:23+01:00 2008-11-11T03:00:23+01:00 2008-11-11T03:00:23+01:00 http://www.vaccinerx.com/news/anthrax/emergent-biosolutions-submits-proposal-of-a-recombinant-protective-antigen-anthrax-vaccine-20081111-577-56.html Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has submitted a proposal in response to a request for proposal (RFP) issued by the U.S. Department of Health and Human Services (HHS) for a recombinant protective antigen anthrax vaccine (rPA).... African Researchers Hail Significant Funding Boost for Malaria Vaccine Research 2008-11-06T03:00:23+01:00 2008-11-06T03:00:23+01:00 2008-11-06T03:00:23+01:00 http://www.vaccinerx.com/news/malaria/african-researchers-hail-significant-funding-boost-for-malaria-vaccine-research-20081106-576-56.html African malaria research experts have welcomed announcements by Roll Back Malaria (RBM) and the Bill Melinda Gates Foundation which pledged continued support and additional funding for malaria vaccine research. AMANET (African Malaria Network Trust),... Bird Flu Vaccine Protects People and Pets 2008-10-30T03:00:23+01:00 2008-10-30T03:00:23+01:00 2008-10-30T03:00:23+01:00 http://www.vaccinerx.com/news/bird-flu/bird-flu-vaccine-protects-people-and-pets-20081030-578-56.html A single vaccine could be used to protect chickens, cats and humans against deadly flu pandemics, according to an article published in the November issue of the Journal of General Virology. The vaccine protects birds and mammals against... HIV Vaccine - Thailand Trial Clarification 2007-05-02T17:11:10+01:00 2007-05-02T17:11:10+01:00 2007-05-02T17:11:10+01:00 http://www.vaccinerx.com/news/latest/hiv-vaccine---thailand-trial-clarification-20070502-239-56.html The HIV Vaccine trial in Thailand will not be reporting final results in July as reported here yesterday, according to a clarification received from Charles Dasey, Public Affairs Officer for the U.S. Army Medical Research... Ground-breaking, lifesaving TB vaccine a step closer 2008-10-27T03:00:23+01:00 2008-10-27T03:00:23+01:00 2008-10-27T03:00:23+01:00 http://www.vaccinerx.com/news/latest/ground-breaking-lifesaving-tb-vaccine-a-step-closer-20081027-580-56.html Researchers at Aberystwyth University, following a number of years of investment by the Biotechnology and Biological Sciences Research Council (BBSRC), have licensed ground-breaking research to a non-profit product development partnership working to develop new, more effective vaccines against Tuberculosis... Bill Gates Announces $168 Million to Develop Next-Generation Malaria Vaccine 2008-10-16T03:00:23+01:00 2008-10-16T03:00:23+01:00 2008-10-16T03:00:23+01:00 http://www.vaccinerx.com/news/latest/bill-gates-announces-168-million-to-develop-next-generation-malaria-vaccine-20081016-575-56.html Bill Gates announced that the Bill Melinda Gates Foundation will provide $168.7 million to PATH for its Malaria Vaccine Initiative to develop vaccines for malaria – a disease that kills thousands of African children every day. The PATH... Malaria vaccine trials begin using 'chimpanzee virus' 2008-10-15T03:00:23+01:00 2008-10-15T03:00:23+01:00 2008-10-15T03:00:23+01:00 http://www.vaccinerx.com/news/latest/malaria-vaccine-trials-begin-using-chimpanzee-virus-20081015-574-56.html Trials are underway, funded by the Welcome Trust, for a new vaccine to combat the most deadly form of malaria. For the first time ever, researchers will use a virus found in chimpanzees to boost the efficacy of... FDA and PATH Malaria Vaccine Initiative Announce Research Collaboration 2008-10-14T03:00:23+01:00 2008-10-14T03:00:23+01:00 2008-10-14T03:00:23+01:00 http://www.vaccinerx.com/news/latest/fda-and-path-malaria-vaccine-initiative-announce-research-collaboration-20081014-573-56.html The U.S. Food and Drug Administration has announced a collaboration with the PATH Malaria Vaccine Initiative (PATH-MVI) to develop laboratory tests to better predict the level of safety and effectiveness of experimental malaria vaccines before they are used... CDC Awards $16.9 Million Contract to Improve Capabilities to Combat Pandemic, Seasonal Influenza 2008-10-10T03:00:23+01:00 2008-10-10T03:00:23+01:00 2008-10-10T03:00:23+01:00 http://www.vaccinerx.com/news/influenza/cdc-awards-16.9-million-contract-to-improve-capabilities-to-combat-pandemic-seasonal-influenza-20081010-572-56.html The Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/) has awarded a $16.9 million contract to American Type Culture Collection (ATCC) (http://www.atcc.org/) of Manassas, Va. to implement the CDC Influenza Reagent Resource (CDC-IRR), a secure, Web-based system...